P362: OUTCOMES IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING HEMATOPOIETIC CELL TRANSPLANTATION USING REAL-WORLD DATA FROM HARMONY
Alexander Russell-Smith,
Riley Taiji,
Paule Tétreault-Langlois,
Samy Gallienne,
Raluca Ionescu-Ittu,
Francis Vekeman,
Anthony Moorman,
Michael Doubek,
Saara Tikka,
Amin Turki
Affiliations
Alexander Russell-Smith
1 Pfizer Ltd, Sanwich, United Kingdom
Riley Taiji
2 STATLOG, Montreal, Canada
Paule Tétreault-Langlois
2 STATLOG, Montreal, Canada
Samy Gallienne
2 STATLOG, Montreal, Canada
Raluca Ionescu-Ittu
2 STATLOG, Montreal, Canada
Francis Vekeman
2 STATLOG, Montreal, Canada
Anthony Moorman
3 Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom
Michael Doubek
4 Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
Saara Tikka
5 Pfizer Oy, Helsinki, Finland
Amin Turki
6 Department of Hematology and Stem Cell Transplantation, Computational Hematology Lab, University Hospital Essen, Essen, Germany
